Table 2.
Results of association study of common CNVs
| Chr | Regions | Type | Foreground (case/control) |
Background (case/control) |
Odds ratio (OR) | P values | Genes included* |
|---|---|---|---|---|---|---|---|
| chr1 | 16,894,856–16,929,044 | Duplication | 33/17 | 337/363 | 2.09 | 1.06E−02 | |
| chr1 | 16,949,054–16,987,299 | 48/20 | 307/340 | 2.66 | 1.99E−04 | MST1L | |
| chr6 | 103,854,114–103,868,754 | 79/106 | 301/274 | 1.47 | 1.39E−02 | ||
| chr8 | 7,665,275–7,836,800 | 142/108 | 239/258 | 1.42 | 1.49E−02 | DEFB104A; PRR23D2; SPAG11A; DEFB103A; DEFB105A; DEFB107A; DEFB4A; DEFB106A | |
| chr8 | 7,202,021–7,259,767 | 61/38 | 262/278 | 1.70 | 1.09E−02 | ZNF705G | |
| chr8 | 12,260,380–12,487,426 | 49/28 | 323/345 | 1.87 | 7.56E−03 | FAM86B2; FAM66A | |
| chr9 | 68,055,004–68,312,791 | 32/15 | 231/270 | 2.49 | 3.01E−03 | ||
| chr11 | 4,928,581–4,930,605 | 33/57 | 351/324 | 1.87 | 4.25E−03 | ||
| chr16 | 21,297,471–21,501,135 | 182/147 | 81/114 | 1.74 | 1.52E−03 | NPIPB3 | |
| chr20 | 1,509,580–1,520,451 | Deletion | 303/331 | 63/42 | 1.64 | 1.33E−02 | |
| chr1 | 173,063,028–173,064,310 | 87/120 | 253/230 | 1.52 | 7.92E−03 | ||
| chr1 | 110,034,497–110,047,804 | 89/121 | 216/196 | 1.49 | 1.11E−02 | ||
| chr6 | 29,979,615–30,012,844 | 49/86 | 199/171 | 2.04 | 3.45E−04 | HCG4B | |
| chr6 | 29,945,293–29,989,326 | 43/70 | 121/110 | 1.79 | 8.40E−03 | HCP5B | |
| chr7 | 133,446,174–133,449,737 | 41/71 | 327/296 | 1.91 | 1.33E−03 | ||
| chr10 | 45,905,767–46,573,925 | 129/97 | 254/288 | 1.51 | 6.14E−03 | SYT15; NPY4R; GPRIN2 | |
| chr14 | 40,697,979–40,727,099 | 47/28 | 269/289 | 1.80 | 1.27E−02 |
*Genes include functional genes and lncRNA genes